MeMed Secures $93M Financing To Commercialize Diagnostics Platform

The company will use the money to fund its US commercialization strategy and continue to develop its host response-based product pipeline.

MeMeds Key testing platform

Israel-based diagnostics manufacturer MeMed has secured $93m in private financing, it announced January 10. 

This latest financing brings the total raised by the company to over $200m. In the past, the company has also received support from the U

More from Diagnostics

More from Device Area